Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Dec 01, 2024
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Dec 03, 2024